Purchases and Sales Made in Q2 2022 in Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT) during Q2 2022. The information is specifically focused on institutions that hold shares of Cogent Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2.03K- 89.01% |
$7.97K - $19.8K
|
251
$2.23K
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-4.42K- 89.42% |
$17.3K - $43K
|
523
$4.65K
|
|
|
Aug 01, 2022
Q2 2022
|
Pro Share Advisors LLC
|
SELL
|
- |
-11.1KClosed |
$43.5K - $108K
|
0
$0
|
|
|
Feb 14, 2023
Q2 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-11.4K- 1.91% |
$44.7K - $111K
|
585K
$5.21M
|
|
|
Aug 15, 2022
Q2 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-11.4K- 1.91% |
$44.7K - $111K
|
585K
$5.21M
|
|
|
Aug 11, 2022
Q2 2022
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-13.8K- 33.64% |
$54K - $134K
|
27.2K
$242K
|
|
|
Aug 12, 2022
Q2 2022
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-19.5KClosed |
$76.3K - $189K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-31.4K- 91.85% |
$123K - $305K
|
2.78K
$24.8K
|
|
|
Aug 15, 2022
Q2 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-32.7K- 13.55% |
$128K - $318K
|
209K
$1.86M
|
|
|
Aug 15, 2022
Q2 2022
|
Atom Investors LP
Austin, TX |
SELL
|
- |
-35.7K- 30.9% |
$140K - $347K
|
79.8K
$710K
|
|
|
Aug 15, 2022
Q2 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-36.8KClosed |
$144K - $358K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Veritable, L.P.
Newtown Square, PA |
SELL
|
- |
-39.8K- 69.77% |
$156K - $387K
|
17.2K
$153K
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-76.8K- 17.2% |
$301K - $748K
|
370K
$3.29M
|
|
|
Aug 15, 2022
Q2 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-99.8K- 3.13% |
$391K - $971K
|
3.09M
$27.5M
|
|
|
Aug 11, 2022
Q2 2022
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-149K- 14.21% |
$585K - $1.45M
|
901K
$8.02M
|
|
|
Aug 15, 2022
Q2 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-150KClosed |
$588K - $1.46M
|
0
$0
|
|
|
Aug 03, 2022
Q2 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-186KClosed |
$731K - $1.81M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-224KClosed |
$876K - $2.18M
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Atlas Venture Associates Ix, LLC
Boston, MA |
SELL
|
- |
-450K- 49.08% |
$1.76M - $4.38M
|
467K
$4.15M
|
|
|
Aug 15, 2022
Q2 2022
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-452K- 34.52% |
$1.77M - $4.4M
|
857K
$7.63M
|
|
|
Aug 03, 2022
Q2 2022
|
Candriam S.C.A.
|
SELL
|
- |
-502K- 28.64% |
$1.97M - $4.89M
|
1.25M
$11.1M
|
|
|
Aug 10, 2022
Q2 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-558K- 21.03% |
$2.19M - $5.43M
|
2.09M
$18.6M
|
|
|
Aug 15, 2022
Q2 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-800K- 47.06% |
$3.14M - $7.78M
|
900K
$8.01M
|
|
|
Aug 15, 2022
Q2 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-853KClosed |
$3.35M - $8.3M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.03M- 32.69% |
$4.06M - $10.1M
|
2.13M
$19M
|